Medxai is a company specializing in delivering best-in-class machine learning products to healthcare practitioners, closely collaborating with medical domain experts from concept to certification.

They focus on innovation in diagnosis to enhance the capabilities of healthcare professionals for quicker, more accurate, and more informative diagnoses. Their approach combines the expertise of medical professionals with AI, emphasizing transparency and interpretability over complex black-box models to ensure explainability for patients and support prescriptive modeling.

Medxai collaborates closely with researchers and doctors to develop novel biostatistical methods or biomedical insights, sharing their findings with the scientific community. Their mission is to bring data science into clinical practice, assisting doctors in providing the best possible care to patients.

The company originated from ABN AMRO's Beyond Banking hackathons in 2017 and 2018, where data scientists from the financial sector entered the field of genetics and medical data under expert supervision. Medxai was officially formed after these events, continuing their focus on healthcare challenges and innovation.

MEDxAI is financially supported by the European Union and Kansen voor West. They have ongoing collaborations with partners like EZA and the UMCU for implementing clinical decision support systems.

The team includes experienced professionals such as Tjebbe (CEO), Bram (CTO), Evgeny (Machine Learning Engineer), and Sebastiaan (Machine Learning Engineer), each bringing significant expertise in healthcare innovation, applied mathematics, machine learning, and software engineering.